Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C47H75NO17 |
Molecular Weight | 926.0949 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@]([H])(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2
InChI
InChIKey=VQOXZBDYSJBXMA-NQTDYLQESA-N
InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1
Molecular Formula | C47H75NO17 |
Molecular Weight | 926.0949 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.drugbank.ca/drugs/DB00646Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14781786 | https://www.ncbi.nlm.nih.gov/pubmed/25082221 | https://www.ncbi.nlm.nih.gov/pubmed/27379602
Sources: https://www.drugbank.ca/drugs/DB00646
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14781786 | https://www.ncbi.nlm.nih.gov/pubmed/25082221 | https://www.ncbi.nlm.nih.gov/pubmed/27379602
Nystatin A1 is the one of the first member of important class of a macrocyclic polyene and poly-ol antibiotics isolated from Streptomyces noursei in 1950. Nystatin A1 binds to ergosterol, a major component of the fungal cell membrane. When present in sufficient concentrations, it forms pores in the membrane that lead to K+ leakage, acidification, and death of the fungus. Nystatin A1 is major component of Nystatin an important antifungal antibiotic, which for over half a century has been broadly used in medicine for the treatment of topical fungal infections caused by a broad spectrum of fungal pathogens comprising yeast-like and filamentous species.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2364028 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24924305 |
570.0 µM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Antimicrobial activity of Calotropis procera Ait. (Asclepiadaceae) and isolation of four flavonoid glycosides as the active constituents. | 2013 Jul |
|
Anthelmintic and antimicrobial activity of methanolic and aqueous extracts of Euphorbia helioscopia L. | 2013 Mar |
|
Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. | 2014 May |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24924305
The minimal inhibitory concentration (MIC) was determined for C. albicans . Nystatin A1previously prepared in DMSO were diluted in the RPMI-1640 medium to give final concentration ranges of 0.03125–16 mkg/ml . Nystatin A1 MICs was from 0.5 mkg/ml for Candida albicans ATCC 10231.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:59:26 GMT 2023
by
admin
on
Fri Dec 15 15:59:26 GMT 2023
|
Record UNII |
W1LX4T91WI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C514
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C75988
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
PRIMARY | |||
|
11286230
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
PRIMARY | |||
|
W1LX4T91WI
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
PRIMARY | |||
|
34786-70-4
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
PRIMARY | |||
|
m8095
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID80872323
Created by
admin on Fri Dec 15 15:59:26 GMT 2023 , Edited by admin on Fri Dec 15 15:59:26 GMT 2023
|
PRIMARY |